RxDoctor Payments Data

Christian Hester, MD

Ophthalmology · Little Rock, ARNPI 1154522407

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,467 of the $3,945 with a category attached, or 62.5%. 16 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 38.9% of the total. Reporting peaked in 2024 at $1,774 and has fallen 72.7% since, to $485 in 2025. Among ophthalmology clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,945in general payments, 2019–2025

Across 77 payments — averaging $51.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$2K
  • Glaukos Corporation$812
  • AbbVie$571
  • Alcon$272
  • Oyster Point Pharma, Inc.$187
  • Biotissue Holdings Inc.$107
  • plus $464 from 10 others

What the payments were for

  • Speaking & faculty fees$52613%
  • Travel & lodging$93324%
  • Food & beverage$2,46763%
  • Gifts$190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,945 in reported general payments places this provider in the 90th percentile of 125 ophthalmology providers in Arkansas.

See all ophthalmology providers in Arkansas

Medicare billing

Part B allowed, 2024
$440,640
Medicare patients
821
Services billed
2,637

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorometholone225$16,467
Prednisolone Acetate359$14,481
ValacyclovirValacyclovir Hcl54$1,864
MoxifloxacinMoxifloxacin Hcl57$1,583
Loteprednol Etabonate11$1,548
Dexamethasone Sodium Phosphate21$1,172
Tobramycin-DexamethasoneTobramycin/Dexamethasone28$957
Doxycycline Hyclate40$716
ErythromycinErythromycin Base46$579
Ketorolac Tromethamine24$439
Ofloxacin32$429
Timolol Maleate38$208
Latanoprost13$131
Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim12$77

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →